Women's Health: The Category Nobody Built Yet

The demand in women's health has been obvious for years, yet the right products still don't exist. Citruslabs surveyed 730 US women managing PMS, PMDD, fertility, or menopause to find out what they actually think of the products marketed to them. The answer changes completely depending on which of the four you ask, and each one wants something the others don't. The findings point to four distinct product gaps, a trust economy that's quietly shifted away from doctors, and one standard that applies across all of it: evidence on the actual formulation, for the actual population. Real Consumer Data: Insights from US women across PMS, PMDD, fertility, and menopause, on what they take, what they'd pay, and what's missing. Four Conditions, Four Verdicts: Diagnosis, not product choice, is what separates satisfied PMDD consumers from frustrated ones. Fertility users are the most prepared consumers in the survey and the worst served. Menopause gets met with indifference more than any other condition. PMS remains the most dissatisfied category despite heavy existing use. The New Trust Standard: Clinical research has overtaken a doctor's recommendation as the top trust signal. Vague claims like "supports hormonal balance" are now the single biggest red flag on a label. This report is for you if... You're building a brand and want to know where the big open spaces in women's health are. You work in product or marketing and want to understand what each women's health consumer group actually wants from a formula, a label, and a product claim. You work in women's health as a clinician, researcher, investor, or advocate, and want survey data on how 730 women actually manage PMS, PMDD, fertility, and (peri)menopause when the system leaves them to figure it out alone. You're managing one of these conditions yourself and want to see, in numbers, that you're not the only one stacking three brands and reading labels like a scientist. Ready to see what women managing PMS, PMDD, fertility, and (peri)menopause actually want, and why nobody's built it yet? Get the full report straight to your inbox.